1Calhoun D A, Zaman M A, Nishizaka M K. Resistant hypertension[J].Curr Hypertens Rep,2002,4(3):221 -228.
2Duprez D A. Role of the renin-angiotensin-aldosterone system invascular remodeling and inflammation: A clinical review [J].Hy-pertension,2006:983-991.
3Ahmed M I,Calhoun D A.Resistant hypertension:bad and gettingworse[J].Hypertension,2011,57(6):1045-1046.
5Handler J.Malingering:an unusual cause of resistant hypeaension[J].J Clin Hypertens,2012,14(7):475-478.
6Sowers J R, Whaley-Connell A, Epstein M. Narrative review: Theemerging clinical implications of the role of aldosterone in themetabolic syndrome and resistant hypertension [J].Ann InternMed,2009,50:776-783.
7Nishi Zaka M K, Zaman M A, Calhovn D A. Efficacy of low dosespironolactone in subjects with resistant hypertension [J]. Am JHypertension,2003,16:925-630.
6Calhoun DA, Jones D, Textor S, et al. Resistant hypertension : diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Bloom Pressure Research [ J ]. Hypertension , 2008 ( 51 ) : 1403-1419.
